Found 11 matching trials
JSKN003 Combined Treatment of HER2-positive Gastric Cancer PHASE2 This study is designed to evaluate the safety and efficacy of JSKN003 combi...
Show More Location
Multiple Locations
Learn More & Join Trial
First-In-Human Study in Subjects With Advanced or Metastatic Solid Malignant Tumors PHASE1 This study is an open-label, multicenter, first-in-human, Phase I, dose esc...
Show More Location
Breast Cancer Research Centre
Learn More & Join Trial
JSKN003 Versus Treatment Of Physician'S Choice For HER2-low, Unresectable and/or Metastatic Breast Cancer Subjects PHASE3 This study is a randomized controlled, open-label, multicenter phase III cl...
Show More Learn More & Join Trial
JSKN033 in Patients With Advanced or Metastatic Solid Malignant Tumors PHASE1 This study is an open-label, multicenter, first-in-human, Phase I/II (dose ...
Show More Location
Scientia Clinical Research
Learn More & Join Trial
Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy PHASE2 The purpose of this study is to establish a prospective, single-center plat...
Show More Location
Fudan University Shanghai Cancer Center Shanghai, China, 200032
Learn More & Join Trial
A Study of JSKN003 Versus Trastuzumab in Combination With Pertuzumab and Docetaxel as First-Line Treatment for HER2-Positive Recurrent or Metastatic Breast Cancer PHASE2 This study is a randomized, controlled, open-label, multicenter, phase II s...
Show More Location
Multiple Locations
Learn More & Join Trial
JSKN003 Versus Trastuzumab Emtansine (T-DM1) for HER2-Positive, Advanced Breast Cancer PHASE3 This study is designed to compare the safety and efficacy of JSKN003 versus...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
JSKN003 Versus Physician Choiced Treatment in Patients With HER2-positive and Advanced Colorectal Cancer Who Had Failed to Respond to Oxaliplatin, 5-Fu, and Irinotecan PHASE3 The study is being conducted to evaluate the efficacy and safety of JSKN003...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety and Tolerability of JSKN003 in Chinese Subjects With Advanced Solid Tumors PHASE1 This is an open, multicenter study of phase I/II in Chinese subjects with u...
Show More Status
Active Not Recruiting
Location
Beijing Cancer Hospital
Learn More & Join Trial
JSKN003 in Platinum-Resistant, Relapsed Epithelial Ovarian Cancer PHASE3 This study is a randomized, open-label, controlled, phase III study to eval...
Show More Location
Multiple Locations
Learn More & Join Trial